<DOC>
	<DOCNO>NCT00016978</DOCNO>
	<brief_summary>Phase II trial study effectiveness combine oxaliplatin , fluorouracil leucovorin treat patient metastatic colorectal cancer previously treat irinotecan . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan</brief_title>
	<detailed_description>OBJECTIVES : I . Determine tumor response rate patient treat oxaliplatin , fluorouracil , leucovorin calcium metastatic colorectal cancer previously treat irinotecan . II . Determine time tumor progression , time treatment failure , overall survival patient treat regimen . III . Determine toxicity regimen patient population . IV . Assess quality life patient treat regimen . OUTLINE : This multicenter study . Patients receive oxaliplatin IV 2 hour day 1 15 leucovorin calcium fluorouracil IV day 1 , 8 , 15 . Treatment repeat every 28 day absence disease progression unacceptable toxicity . Patients achieve confirm complete response 2 consecutive course may discontinue study treatment investigator discretion . Quality life assess baseline , approximately every 6-8 week treatment , last course treatment . Patients follow every 3 month 5 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis metastatic colorectal adenocarcinoma incurable surgery amenable radiotherapy curative intent Progressive disease 3 month completion prior weekly irinotecan , fluorouracil , leucovorin calcium chemotherapy regimen At least 1 measurable lesion At least 20 mm least one dimension No known CNS metastases carcinomatous meningitis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 12 week Absolute neutrophil count great 2,000/mm3 Platelet count least 100,000/mm3 Bilirubin great 0.5 mg/dL upper limit normal ( ULN ) AST great 5 time ULN Creatinine great 1.5 time ULN OR creatinine clearance great 60 mL/min No unstable angina No symptomatic congestive heart failure No serious uncontrolled cardiac arrhythmia No active uncontrolled infection No evidence serious illness No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer noninvasive carcinoma Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : No concurrent sargramostim ( GMCSF ) At least 4 week since prior chemotherapy No 1 prior chemotherapy regimen advance colorectal cancer Prior adjuvant chemotherapy allow No prior radiotherapy 25 % bone marrow At least 4 week since prior major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>